Literature DB >> 379229

A method to evaluate the capacity of monocytes and macrophages to inhibit multiplication of an intracellular pathogen.

R McLeod, J S Remington.   

Abstract

A new method to assess intracellular inhibition of multiplication or killing by normal and activated mouse peritoneal macrophages, human peripheral blood monocytes, and human monocyte-derived macrophages is described. This method involves measurement of incorporation of [3H]uracil into nucleic acids of the obligate intracellular parasite Toxoplasma gondii. The method utilizes the observation by Pfefferkorn and Pfefferkorn (1977) that [3H]uracil is incorporated in substantially greater amounts by T. gondii than by certain mammalian cell types. Differential uptake of [3H]uracil by Toxoplasma-infected and uninfected cultures allows for evaluation of the ability of macrophages or monocytes to inhibit or kill this organism. This method has been adapted to microsystem.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 379229     DOI: 10.1016/0022-1759(79)90235-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  18 in total

1.  Semiautomated assessment of in vitro activity of potential antileishmanial drugs.

Authors:  J D Berman; J V Gallalee
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

2.  Prevention of peroral and congenital acquisition of Toxoplasma gondii by antibody and activated macrophages.

Authors:  P Eisenhauer; D G Mack; R McLeod
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

3.  Specific and nonspecific mediation of protective immunity to Toxoplasma gondii.

Authors:  L Reyes; J K Frenkel
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

4.  Microbicidal activity of monocyte derived macrophages in AIDS and related disorders.

Authors:  L J Eales; O Moshtael; A J Pinching
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

5.  Enzyme immunoassay for evaluation of Toxoplasma gondii growth in tissue culture.

Authors:  A Merli; A Canessa; G Melioli
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

6.  New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.

Authors:  D G Mack; R McLeod
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

7.  Cellular defenses against Toxoplasma gondii in newborns.

Authors:  C B Wilson; J E Haas
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

8.  Role of lymphocyte blastogenesis to Toxoplasma gondii antigens in containment of chronic, latent T. gondii infection in humans.

Authors:  R McLeod; R G Estes
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

9.  Role for endogenous and acquired peroxidase in the toxoplasmacidal activity of murine and human mononuclear phagocytes.

Authors:  R M Locksley; C B Wilson; S J Klebanoff
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

10.  Oxidant-mediated damage of Leishmania donovani promastigotes.

Authors:  N E Reiner; J W Kazura
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.